Revolution Medicines competitors

Revolution Medicines Competitors include ProImmune, LGC Biosearch Technologies, Loxo Oncology and Fate Therapeutics.
Add company...
Revolution Medicines
REVOLUTION Medicines is redesigning evolution's products to treat serious diseases. The company discovers and develops new drugs by deploying our innovative product engine to reconfigure substances that are inherently rich with biological function as a result of natural selection.
ProImmune
ProImmune is a private biotechnology company that specializes in providing products and services for epitope discovery, immune monitoring and the design of biological drugs with reduced immunogenicity risk.
LGC Biosearch Technologies
LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Fate Therapeutics
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Founding Date
Founding Date
2015
Founding Date
2000
Founding Date
1842
Founding Date
2013
Founding Date
2007
Type
Type
Private
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Redwood City, US HQ
Locations
Oxfordshire, GB HQ
Sarasota, US
Locations
Teddington, GB HQ
Locations
Stamford, US HQ
South San Francisco, US
Locations
San Diego, US HQ
Employees
Employees
695% increase
Employees
21
Employees
N/A
Employees
4757% increase
Employees
66
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
5.1 b
Valuation ($)
827.1 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
2.4 k
Twitter followers
46
Twitter followers
853

Financial

Net income
Net income
N/A
Net income
N/A
Net income
(£4.3m) (FY, 2017)
Net income
($148.9m) (FY, 2017)
Net income
($43m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 126m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 57m
Total funding raised
$ 200.4m
For sources of this data, please see the company profileDownload Excel

View company profiles

ProImmune
HQ
Oxfordshire, GB
Employees
21

ProImmune is a private biotechnology company that specializes in providing products and services for epitope discovery, immune monitoring and the design of biological drugs with reduced immunogenicity risk.

View company
LGC Biosearch Technologies
HQ
Teddington, GB

LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.

View company
Loxo Oncology
HQ
Stamford, US
Employees
47

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

View company
Fate Therapeutics
HQ
San Diego, US
Employees
66

Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.

View company